Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review. [PDF]
Zhang Z, Liao L, Zhou H, Xiang W, Li J.
europepmc +1 more source
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results. [PDF]
Pittock SJ +14 more
europepmc +1 more source
Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome. [PDF]
Eliaçık S.
europepmc +1 more source
Seronegative Neuromyelitis Optica Spectrum Disorder in a Six-Year-Old Patient: A Case Report. [PDF]
Pinacho-Velázquez JL +4 more
europepmc +1 more source
Patient-reported outcomes in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder on inebilizumab therapy: a cross-sectional study. [PDF]
Yin H, Hao M, Xu Y.
europepmc +1 more source
Subtle Neurological Manifestations With Unexpected Lesion Extension After High-Dose Methylprednisolone in Neuromyelitis Optica Spectrum Disorder. [PDF]
Yamada G, Okita K, Kuno T, Katada E.
europepmc +1 more source
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments. [PDF]
Bilodeau PA +11 more
europepmc +1 more source
Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. [PDF]
Kittipadakul S +6 more
europepmc +1 more source
Clinicoradiologic profile of neuromyelitis optica spectrum disorder in a Kashmiri cohort: a prospective observational cohort study. [PDF]
Mir TA +4 more
europepmc +1 more source
The Impact of COVID-19 Infection and Vaccination on Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease: A Narrative Review. [PDF]
Hernandez J +4 more
europepmc +1 more source

